Loading Page
Dr. Katryn N. Furuya, MD is a pediatric transplant hepatologist in BRONX, NY specializing in pediatric transplant hepatology (liver transplant medicine). She graduated from University of Toronto Faculty of Medicine. Dr. Katryn N. Furuya, MD is affiliated with Albert Einstein College of Medicine and UW Health.
Dr. Katryn N. Furuya, MD graduated from University of Toronto Faculty of Medicine. She completed residency at The Hospital for Sick Children. She is certified by the Pediatric Gastroenterology Pediatric Transplant Hepatology and has a state license in Wisconsin.
Medical School: University of Toronto Faculty of Medicine
Residency: The Hospital for Sick Children
Board Certification: Pediatric Gastroenterology Pediatric Transplant Hepatology
Licensed In: Wisconsin
Dr. Katryn N. Furuya, MD does not have any reviews yet, be the first to leave a review of Dr. Katryn N. Furuya, MD here: Leave a Review
These charts describe general payments received by Dr. Katryn N. Furuya, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$38,567
Kanuma $34,621 |
SOLIRIS $3,946 |
|||||
|
$12,949
Livmarli $10,999 |
$1,950 |
|||||
|
$2,668
$2,668 |
||||||
|
$1,628
(820) Cholbam $1,628 |
||||||
|
$147
SUCRAID $147 |
||||||
|
$550
Neuro-Ultrasonic Aspiration Products $110 |
OLYSIO $105 |
Humira $97 |
REMICADE $95 |
TACHOSIL $82 |
Other $61 |
| $16,868 | |
| $15,233 | |
| $14,300 | |
| $7,500 | |
| $2,601 | |
| $7 |
Dr. Katryn N. Furuya, MD has received 11 research payments totaling $52,850.
Katryn N Furuya, MD, is Director, Pediatric Hepatology, at the Children’s Hospital at Montefiore Einstein and Professor, Pediatrics, at our Albert Einstein College of Medicine. Dr Furuya’s clinical focus is pediatric hepatology, including the diagnosis and management of pediatric liver disease and pediatric liver transplantation, with particular expertise in acute liver failure, biliary atresia, metabolic liver disease, viral hepatitis and MASLD (metabolic dysfunction associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease.
